| |
Total
|
Age (years)
|
Follow-up (months)
|
|---|
|
< 60
|
≥60
|
2–59
|
60–119
|
≥120
|
|---|
|
SIR
|
O/E
|
CI
|
SIR
|
SIR
|
SIR
|
SIR
|
SIR
|
|---|
|
Leukaemia
|
3.07#
|
(22/7.16)
|
(1.92–4.65)
|
3.86#
|
1.60
|
3.16#
|
3.68#
|
2.05
|
|
Urinary bladder
|
1.99
|
(10/5.03)
|
(0.95–3.66)
|
2.90#
|
1.35
|
2.01
|
2.93
|
0.85
|
|
Lung, bronchus
|
1.80#
|
(81/44.89)
|
(1.43–2.24)
|
2.61#
|
1.01
|
1.26
|
2.64#
|
1.99#
|
|
Rectum, rectosigmoid junction
|
1.42#
|
(47/33.04)
|
(1.05–1.89)
|
1.67#
|
1.08
|
1.53
|
1.35
|
1.27
|
|
Thyroid
|
1.34#
|
(206/153.16)
|
(1.17–1.54)
|
1.35#
|
1.32
|
1.57#
|
1.21
|
0.95
|
|
Colon
|
1.58#
|
(122/77.38)
|
(1.31–1.88)
|
2.00#
|
1.03
|
1.69#
|
1.34
|
1.60#
|
|
Ascending colon
|
1.77#
|
(25/14.14)
|
(1.14–2.61)
|
2.26#
|
1.28
|
1.60
|
1.31
|
2.61#
|
|
Transverse colon
|
2.43#
|
(14/5.77)
|
(1.33–4.07)
|
4.07#
|
0.71
|
1.79
|
1.93
|
4.22#
|
|
Descending colon
|
1.17
|
(23/19.64)
|
(0.74–1.76)
|
1.43
|
0.77
|
1.52
|
1.50
|
0.00#
|
|
Rectum
|
1.45#
|
(48/33.13)
|
(1.07–1.92)
|
1.72#
|
1.08
|
1.52
|
1.34
|
1.40
|
|
Other and unspecified
|
2.55#
|
(12/4.71)
|
(1.32–4.45)
|
4.01#
|
1.21
|
3.74#
|
0.00
|
2.94
|
|
Female breast
|
1.26#
|
(128/101.85)
|
(1.05–1.49)
|
1.30#
|
0.99
|
1.29#
|
1.47#
|
0.87
|
|
Kidney parenchyma
|
1.43
|
(12/8.37)
|
(0.74–2.50)
|
1.49
|
1.34
|
1.64
|
1.78
|
0.54
|
|
Renal pelvis, other urinary
|
2.38
|
(5/2.10)
|
(0.77–5.56)
|
2.31
|
2.43
|
3.02
|
0.00
|
3.69
|
|
Pancreas
|
1.25
|
(20/15.94)
|
(0.77–1.94)
|
1.72
|
0.89
|
0.91
|
2.55#
|
0.51
|
|
Non-Hodgkin lymphoma
|
0.88
|
(11/12.43)
|
(0.44–1.58)
|
1.13
|
0.45
|
1.09
|
0.60
|
0.74
|
|
Bile ducts, other biliary
|
1.43
|
(26/18.23)
|
(0.93–2.09)
|
2.20#
|
0.86
|
1.57
|
1.01
|
1.61
|
|
Stomach
|
0.89
|
(67/75.35)
|
(0.69–1.13)
|
1.15
|
0.55#
|
0.56#
|
1.34
|
1.15
|
|
Liver
|
0.68
|
(16/23.54)
|
(0.39–1.1)
|
0.81
|
0.50
|
0.71
|
0.48
|
0.86
|
|
Gallbladder
|
0.64
|
(6/9.43)
|
(0.23–1.38)
|
1.21
|
0.19
|
0.64
|
0.39
|
0.92
|
|
Small intestine
|
1.93
|
(4/2.07)
|
(0.53–4.94)
|
3.37
|
0.00
|
1.89
|
0.00
|
4.38
|
|
All excluding POFT
|
1.29#
|
(838/647.47)
|
(1.21–1.38)
|
1.47#
|
0.91
|
1.33#
|
1.38#
|
1.11
|
- POFT: peritoneal, epithelial ovarian, and fallopian tubal; SIR: standardised incidence ratio; O/E: observed/expected; CI: confidence interval
- #significant at α = 0.05
